Smithers brings together a highly technical, engaged audience, which makes this collaboration particularly valuable. It allows NAMSA to contribute directly to meaningful industry dialogue and to share practical insights drawn from real regulatory and scientific challenges our clients face.
Regulatory expectations around materials, extractables, and leachables continue to be challenging, while development timelines are tightening. Many organizations are also reassessing legacy data and strategies, making this a very relevant moment to step back and discuss best practices.
A key challenge is how to appropriately utilize chemical characterization and E&L strategies while balancing scientific rigor, regulatory expectations, and practical constraints. And the focus still needs to remain to create data that meaningfully supports patient safety, our whole purpose.
Smithers brings together a highly technical, engaged audience, which makes this collaboration particularly valuable. It allows NAMSA to contribute directly to meaningful industry dialogue and to share practical insights drawn from real regulatory and scientific challenges our clients face.
Attendees will gain practical, immediately applicable insights around E&L strategy, regulatory expectations, or common pitfalls. Just as importantly, it’s a strong forum for peer-to-peer discussion with people who truly understand the space.
